No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis

Journal of Neurochemistry

Volumn 82, Issue 5, 2002, Pages 1229-1238

  Lee, J P ^a   Gerin, C ^b   Bindokas, V P ^b   Miller, R ^c   Ghadge, G ^b   Roos, R P ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adenovirus; ALS; Motor neuron disease; PC12; Superoxide dismutase

Indexed keywords

CATHEPSIN B; CATHEPSIN B INHIBITOR; COPPER ZINC SUPEROXIDE DISMUTASE; ENZYME INHIBITOR; HYDROGEN PEROXIDE; MUTANT PROTEIN; NERVE GROWTH FACTOR; PROTEASOME INHIBITOR; PROTEIN; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ADENOVIRUS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; ENZYME ANALYSIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WILD TYPE;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CATHEPSIN B; CELL DEATH; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; LUMINESCENT PROTEINS; MACROMOLECULAR SUBSTANCES; MULTIENZYME COMPLEXES; MUTATION; NERVE GROWTH FACTOR; NEURONS; OXIDANTS; OXIDATIVE STRESS; PC12 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RECOMBINANT FUSION PROTEINS; SUPEROXIDE DISMUTASE; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA;

EID: 0036724314     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01056.x     Document Type: Article

References (26)

1. Impairment of the ubiquitin-proteasome system by protein aggregation
2. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis
3. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
4. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease
5. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
6. 2+ signal lower in the disease?
7. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity
8. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
9. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis
10. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
11. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection
12. Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression
13. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
14. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
15. Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye
16. Huntington aggregates may not predict neuronal death in Huntington's disease
17. The role of immunophilins in mutant superoxide dismutase-1 linked familial amyotrophic lateral sclerosis
18. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production
19. Role of calpain in adipocyte differentiation
20. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
21. Mutant Cu/Zn-Superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis
22. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry
23. Increasing the protein folding chaperone HSP70 does not affect timecourse of SOD-1 mutant-mediated amyotrophic lateral sclerosis
24. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues
25. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
26. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation